Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-29.92	85.12	121.46
Graham Fair Price	35.30	37.31	27.58
PEG	-89.58	0.45	-4.28
Price/Book	-6.45	20.12	21.51
Price/Cash Flow	-41.58	103.19	176.62
Prices/Earnings	-40.60	31.16	52.47
Price/Sales	-16.47	40.27	48.21
Price/FCF	-41.58	103.19	176.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.75	0.68	0.65
Operating Margin	24.46	0.45	0.36
ROA	65.31	0.04	0.02
ROE	0.10	0.16	57.51
ROIC	0.04	0.06	49.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.02	-43.76
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	< 0.005	0.50	26750.19
EPS QOQ	-0.12	0.70	469.89
FCF QOQ	0.03	0.73	2081.32
Revenue QOQ	< 0.005	0.21	3704.32
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	105.69	94.94	-10.17
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.68	0.66	-2.66
Quick Ratio	1.57	1.31	-16.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.16	19.58	7.80
Cash	12.00	13.88	15.61
Capex	-0.40	-0.43	-6.91
Free Cash Flow	2.21	3.82	72.62
Revenue	8.10	9.78	20.74
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.69	1.39	-18.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.38	5.38	-35.71
Naive Interpretation	Member

06 - Financial Health · Weak

Rating